Announcement PDF July 16, 2024 ASX Announcement Titomic appoints Dr Patricia Dare to Head U.S. Defence and Aerospace efforts Highlights: • Titomic appoints Dr Patricia Dare, a seasoned executive in the US Defence industry having held previous roles at Raytheon, Boeing, and Lockheed, to lead Titomic’s US Defence and Aerospace sales efforts • Engagement represents a further push by Titomic into the US Defence sector following recent advances including Triton Systems (first TKF System sale to US Defence sector, A$1.2 million), OMIC R&D (Oregon based commercial R&D sale, A$1.2 million) and various confidential defence sector engagements (totalling A$0.48 million). Titomic Limited (ASX: TTT) (“Titomic” or the “Company”), the world’s leading provider of cold spray solutions, is pleased to announce the hire of Dr Patricia Dare to lead its defence and aerospace efforts in the United States. This strategic hire reflects Titomic's commitment to expanding its influence and capabilities within the defence sector, particularly within the United States. Dr Dare’s extensive experience and industry know-how will help Titomic forge stronger ties and inroads within the defence sector, enhancing the Company's strategic position and growth prospects. Dr Dare brings a depth of knowledge with over 30 years of experience in the defence industry. With her experience in working for companies like Boeing, Raytheon, Lockheed, and others, she is perfectly suited to drive Titomic's increased sales efforts in the U.S. with a specific focus on the defence industry. Dr Dare has held pivotal roles such as ‘Huntsville Site Executive’ and ‘Requirements and Capabilities Executive Director’ for Raytheon Technologies’ Strategic Deterrence Systems; Business Development Director and Director of Integrated Planning and Schedule for Boeing; Program Director for the Targets and Countermeasures Program, Deputy of Operations and Business Development Director at Lockheed Martin; and numerous program management and engineering leadership roles at Honeywell International. Her credentials include a Doctor of Philosophy in Chemistry from the University of South Florida and executive education courses from the UCLA Anderson Graduate School of Business, Massachusetts Institute of Technologies, Carnegie Mellon, the Defense Acquisition University, and various industry training programs. Additionally, Dr Dare has served on the foundation board of directors for the U.S. Space and Rocket Center, The University of Alabama, Huntsville, Engineering board, Huntsville/Madison Chamber board, and the Committee 100 Board. Dr Patricia Dare commented: “I am thrilled to team up with Titomic at a time when cold spray is emerging as a viable manufacturing, coating, and repair technology for the Aerospace and Defence sector. The technology has an important role to play in further advancing our warfighting capabilities and protecting our Homeland and NATO allies.” 1 Herbert Koeck, Managing Director of Titomic, commented: “I am delighted that Patricia has agreed to work with Titomic and spearhead our US Aerospace and Defence efforts. She has a proven track record in building critical relationships and delivering mission-critical projects to the Defence and Aerospace sector. Titomic has made great progress in developing its capabilities to manufacture high-value add components as well as deliver coating and repair solutions to the defence sector, enabling battle damage repair in-field and forward maintenance, enhancing battle readiness, and prolonging mission capability. With Dr Dare on our team, we are continuing to invest in our US operations and efforts to bring our innovative solutions to the broader Aerospace and Defence market.” This engagement further enhances the Company’s footprint in the US Defence Sector following recent advances in the last few months including the first sale of a TKF System in the United States (to Triton Systems, A$1.2 million), the first sale to the Oregon Manufacturing Innovation Center, a commercial R&D outfit with customers including Sandvik Coromant, Boeing, and Daimler (OMIC R&D, A$1.2 million), as well as the recent engagements with undisclosed defence primes (A$0.48 million, further disclosure restricted due to the International Trade in Arms Regulations and other regulations applicable to the Company). This announcement has been authorised for release by the Board of Titomic Limited. - - - - - END - - - - - 2 INVESTOR ENQUIRIES Geoff Hollis Titomic Chief Financial Officer P: +61 438 168 008 E: chris.healy@titomic.com MEDIA ENQUIRIES Ben Andrews Titomic Global Marketing Manager P: +61 438 759 620 E: ben.andrews@titomic.com REIGN ADVISORY PTY LTD P: +61 2 9174 5388 E: TTT@reignadvisory.com ABOUT TITOMIC LIMITED Titomic Limited (ASX: TTT) is an Australian public company specialising in large integrated solutions for industrialscale metal additive manufacturing, using its patented cold spray additive manufacturing (Cold Spray AM) technology. Titomic provides Cold Spray AM solutions, OEM production and R&D services to the global Aerospace, Defence, Shipbuilding, Oil & Gas, Mining and Automotive industries. Titomic also offers global sales and support for all of its Cold Spray AM activities from its Melbourne Head Office, as well as through local presence in the USA and Europe. Titomic delivers competitive advantages in metal additive manufacturing at every stage in the product value chain. For more information, please visit www.titomic.com. FORWARD LOOKING STATEMENTS Certain statements made in this release are forward-looking statements and are based on Titomic’s current expectations, estimates and projections. Words such as “anticipates”, “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guidance” and similar expressions are intended to identify forward-looking statements. Although Titomic believes the forward-looking statements are based on reasonable assumptions, they are subject to certain risks and uncertainties, some of which are beyond Titomic’s control, including those risks or uncertainties inherent in the process of both developing and commercialising technology. As a result, actual results could materially differ from those expressed or forecasted in the forward-looking statements. The forwardlooking statements made in this release relate only to events as of the date on which the statements are made. Titomic will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this release except as required by law or by any appropriate regulatory authority. 3